vs
Side-by-side financial comparison of FinVolution Group (FINV) and LifeStance Health Group, Inc. (LFST). Click either name above to swap in a different company.
FinVolution Group is the larger business by last-quarter revenue ($479.7M vs $382.2M, roughly 1.3× LifeStance Health Group, Inc.). FinVolution Group runs the higher net margin — 21.2% vs 3.1%, a 18.1% gap on every dollar of revenue. FinVolution Group produced more free cash flow last quarter ($70.6M vs $46.6M).
Volution Group plc is a manufacturer of ventilation equipment for commercial and residential customers. Based in Crawley, West Sussex, the company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.
FINV vs LFST — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $479.7M | $382.2M |
| Net Profit | $101.7M | $11.7M |
| Gross Margin | — | — |
| Operating Margin | 44.6% | 4.7% |
| Net Margin | 21.2% | 3.1% |
| Revenue YoY | — | 17.4% |
| Net Profit YoY | — | 264.1% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $382.2M | ||
| Q3 25 | — | $363.8M | ||
| Q2 25 | — | $345.3M | ||
| Q1 25 | $479.7M | $333.0M | ||
| Q4 24 | — | $325.5M | ||
| Q3 24 | — | $312.7M | ||
| Q2 24 | — | $312.3M | ||
| Q1 24 | — | $300.4M |
| Q4 25 | — | $11.7M | ||
| Q3 25 | — | $1.1M | ||
| Q2 25 | — | $-3.8M | ||
| Q1 25 | $101.7M | $709.0K | ||
| Q4 24 | — | $-7.1M | ||
| Q3 24 | — | $-6.0M | ||
| Q2 24 | — | $-23.3M | ||
| Q1 24 | — | $-21.1M |
| Q4 25 | — | 4.7% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | -0.9% | ||
| Q1 25 | 44.6% | 0.5% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | -5.1% | ||
| Q1 24 | — | -5.6% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | -1.1% | ||
| Q1 25 | 21.2% | 0.2% | ||
| Q4 24 | — | -2.2% | ||
| Q3 24 | — | -1.9% | ||
| Q2 24 | — | -7.5% | ||
| Q1 24 | — | -7.0% |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $745.0M | $248.6M |
| Total DebtLower is stronger | — | $282.8M |
| Stockholders' EquityBook value | — | $1.5B |
| Total Assets | $3.4B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $248.6M | ||
| Q3 25 | — | $203.9M | ||
| Q2 25 | — | $188.9M | ||
| Q1 25 | $745.0M | $134.3M | ||
| Q4 24 | — | $154.6M | ||
| Q3 24 | — | $102.6M | ||
| Q2 24 | — | $87.0M | ||
| Q1 24 | — | $49.5M |
| Q4 25 | — | $282.8M | ||
| Q3 25 | — | $284.6M | ||
| Q2 25 | — | $286.4M | ||
| Q1 25 | — | $288.2M | ||
| Q4 24 | — | $290.0M | ||
| Q3 24 | — | $287.3M | ||
| Q2 24 | — | $288.0M | ||
| Q1 24 | — | $288.8M |
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | $3.4B | $2.1B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | — | $2.1B | ||
| Q1 24 | — | $2.1B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $72.0M | $57.6M |
| Free Cash FlowOCF − Capex | $70.6M | $46.6M |
| FCF MarginFCF / Revenue | 14.7% | 12.2% |
| Capex IntensityCapex / Revenue | 0.3% | 2.9% |
| Cash ConversionOCF / Net Profit | 0.71× | 4.93× |
| TTM Free Cash FlowTrailing 4 quarters | — | $110.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $57.6M | ||
| Q3 25 | — | $27.3M | ||
| Q2 25 | — | $64.4M | ||
| Q1 25 | $72.0M | $-3.1M | ||
| Q4 24 | — | $62.3M | ||
| Q3 24 | — | $22.7M | ||
| Q2 24 | — | $44.1M | ||
| Q1 24 | — | $-21.8M |
| Q4 25 | — | $46.6M | ||
| Q3 25 | — | $17.0M | ||
| Q2 25 | — | $56.6M | ||
| Q1 25 | $70.6M | $-10.3M | ||
| Q4 24 | — | $56.0M | ||
| Q3 24 | — | $17.7M | ||
| Q2 24 | — | $39.0M | ||
| Q1 24 | — | $-26.9M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | 14.7% | -3.1% | ||
| Q4 24 | — | 17.2% | ||
| Q3 24 | — | 5.7% | ||
| Q2 24 | — | 12.5% | ||
| Q1 24 | — | -9.0% |
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | 0.3% | 2.2% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 1.7% |
| Q4 25 | — | 4.93× | ||
| Q3 25 | — | 25.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.71× | -4.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.